Retropsoas Technologies
Frontenac, US · Founded 2017 · Missouri LLC
Retropsoas Technologies develops innovative surgical solutions for spine surgery that combine multiple surgical techniques to improve patient outcomes while minimizing tissue disruption.
Founders & leadership
NE
Nicholas E PoulosExecutive
Reported raises · per SEC filings
Form D private placements$4.4M disclosed across 2 rounds · 2019–2025
▶$3.1MraisedMay 2026 · 38 investors · Other Health CareRule 506(b)
▶$3.1MraisedMay 2026 · 38 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas E PoulosExecutive Officer
- Offering amount
- $4.5M
- Amount sold
- $3.1M
- Minimum investment
- $25K
- Sales commissions
- $1.8K
- Placement agents
- Wilmington Capital Securities, LLC
- First sale
- Jan 2025
- Incorporated
- Limited Liability Company, Missouri
- Federal exemptions
- 06b
▶$1.3MraisedDec 2022 · 6 investors · Other Health CareRule 506(b)
▶$1.3MraisedDec 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas E PoulosExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.3M
- Minimum investment
- $20K
- Proceeds to insiders
- $160K
- First sale
- Dec 2019
- Incorporated
- Limited Liability Company, Missouri, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Retropsoas Technologies do?
- Retropsoas Technologies develops innovative surgical solutions for spine surgery that combine multiple surgical techniques to improve patient outcomes while minimizing tissue disruption.
- How much funding has Retropsoas Technologies raised?
- Retropsoas Technologies has disclosed $4.4M raised across 2 rounds.
- Where is Retropsoas Technologies headquartered?
- Retropsoas Technologies is headquartered in Frontenac, US.